We are live on
!
Find out more
LI
Leap Investments Portfolio holdings
AUM
$152M
1-Year Est. Return
3.6%
This Fund
S&P 500
This Quarter
Est. Return
-4.74%
1 Year Est. Return
-3.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.3M
AUM Growth
–
Cap. Flow
+$83.4M
Cap. Flow
% of AUM
112.26%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
239
New
239
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
InflaRx
IFRX
|
+$2.73M |
| 2 |
HOME
At Home Group Inc.
HOME
|
+$2.11M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$1.72M |
| 4 |
National Beverage
FIZZ
|
+$1.45M |
| 5 |
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
|
+$1.38M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.17% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.9% |
| 4 | Technology | 10.33% |
| 5 | Communication Services | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFYT
26
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $617K | 0.83% |
+23,800
| New | +$598K |
|
27
Helen of Troy
HELE
$649M
| $614K | 0.83% |
+4,700
| New | +$615K |
|
|
BNFT
28
DELISTED
Benefitfocus, Inc.
BNFT
| $595K | 0.8% |
+21,900
| New | +$735K |
|
29
Dell
DELL
$262B
| $579K | 0.78% |
+22,492
| New | +$702K |
|
30
Kohl's
KSS
$2.21B
| $575K | 0.77% |
+12,100
| New | +$730K |
|
31
Nu Skin
NUS
$254M
| $572K | 0.77% |
+11,600
| New | +$590K |
|
32
B&G Foods
BGS
$293M
| $562K | 0.76% |
+26,998
| New | +$623K |
|
33
Varonis Systems
VRNS
$4.58B
| $551K | 0.74% |
+26,700
| New | +$574K |
|
34
Helmerich & Payne
HP
$3.37B
| $550K | 0.74% |
+10,869
| New | +$598K |
|
|
XENT
35
DELISTED
Intersect ENT, Inc
XENT
| $539K | 0.73% |
+23,700
| New | +$639K |
|
|
GWPH
36
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $534K | 0.72% |
+3,100
| New | +$536K |
|
37
Ciena
CIEN
$52.7B
| $514K | 0.69% |
+12,500
| New | +$481K |
|
38
Madrigal Pharmaceuticals
MDGL
$11.4B
| $514K | 0.69% |
+4,900
| New | +$525K |
|
39
Central Garden & Pet Co Class A
CENTA
$2.38B
| $513K | 0.69% |
+26,000
| New | +$523K |
|
40
Axogen
AXGN
$2.2B
| $507K | 0.68% |
+25,600
| New | +$548K |
|
41
Essential Properties Realty Trust
EPRT
$6.76B
| $505K | 0.68% |
+25,200
| New | +$514K |
|
42
Moderna
MRNA
$23B
| $504K | 0.68% |
+34,400
| New | +$739K |
|
43
Flex
FLEX
$41B
| $497K | 0.67% |
+68,871
| New | +$530K |
|
44
Amneal Pharmaceuticals
AMRX
$5.91B
| $478K | 0.64% |
+66,696
| New | +$682K |
|
45
Valmont Industries
VMI
$9.2B
| $469K | 0.63% |
+3,700
| New | +$461K |
|
|
MINI
46
DELISTED
Mobile Mini Inc
MINI
| $459K | 0.62% |
+15,100
| New | +$501K |
|
|
AKRX
47
DELISTED
Akorn Inc
AKRX
| $457K | 0.62% |
+88,800
| New | +$342K |
|
48
Duluth Holdings
DLTH
$154M
| $454K | 0.61% |
+33,400
| New | +$541K |
|
49
Marcus Corp
MCS
$912M
| $452K | 0.61% |
+13,700
| New | +$503K |
|
|
GAP
50
The Gap Inc
GAP
$7.34B
| $450K | 0.61% |
+25,066
| New | +$562K |
|
Similar funds
BC
JT
SCM
SC
BWM
CCM
HF
CCM
Leap Investments's Q2 2019 Portfolio in Review
Q2 2019 is the first quarter with a 13F filing on record for Leap Investments, which disclosed 239 positions worth $74.3M. Its ten largest holdings account for 14% of the portfolio.
Its largest position is InflaRx: 86,182 shares worth $272K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, followed by Healthcare and Industrials.
- Leap Investments's largest Q2 2019 buy was InflaRx: 86,182 shares worth $272K.
- Leap Investments's ten largest holdings make up 14% of its $74.3M portfolio in Q2 2019.
- Leap Investments disclosed 239 positions in Q2 2019, its first 13F filing on record.
Based on Leap Investments's 13F filing for Q2 2019, filed 14 Aug 2019.